<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04170439</url>
  </required_header>
  <id_info>
    <org_study_id>chromium in infertility</org_study_id>
    <nct_id>NCT04170439</nct_id>
  </id_info>
  <brief_title>Added Value of N Acetyle Cysteine to Clomiphene Citrate in PCO</brief_title>
  <official_title>The Added Value of n Acetyle Cysteine and Chromium to Clomiphene Citrate in PCO</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aljazeera Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Aljazeera Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      PCO is one of the factors associated with delayed conception&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In an attempt to induce ovulation Clomiphene citrate can be given in conjunction with N&#xD;
      acetyle cysteine&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 20, 2019</start_date>
  <completion_date type="Actual">May 15, 2020</completion_date>
  <primary_completion_date type="Actual">May 2, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Women who will receive clomiphe citrate plus N acetyle cysteine rally in arm number 1 And women who will receive clomiphene citrate and chromoum in arm number 22</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The number of women who will have mature follicles wih their size and number of mqture follicles The number of women who will have mature follicles</measure>
    <time_frame>within 2 weeks</time_frame>
    <description>Assessment of women in both groups for size and number of follicles</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">108</enrollment>
  <condition>PCO</condition>
  <arm_group>
    <arm_group_label>clomiphene plus metformin plus N acetyle cysteine</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Women who will receive clomiphene citrate plus metformin plus n acetyle cysteine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>clomiphene plus metformin plus chromium</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Women who will receive clomiphene plus metformin plus chromium</description>
  </arm_group>
  <arm_group>
    <arm_group_label>clomiphen citrate plus metformin</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Women who will receive clomiphene plus metformin</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Clomiphene plus metformin plus N acetyle cysteine in arm number 1</intervention_name>
    <description>oral adminstration of clomiphene citrate plus metformin plus N acetyl cysteine or chromium</description>
    <arm_group_label>clomiphene plus metformin plus N acetyle cysteine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Clomiphene citrate plus metformin with chromium</intervention_name>
    <description>oral adminstration of clomiphene citrate plus metformin and chromium</description>
    <arm_group_label>clomiphene plus metformin plus chromium</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>clomiphene citrate plus metformin</intervention_name>
    <description>oral adminstration of clomiphene citrate plus metformin</description>
    <arm_group_label>clomiphen citrate plus metformin</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  women with PCO&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  women who donot have PCO&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Women with PCO</gender_description>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mahmoud Alalfy, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Algezeera</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Algazeerah and Kasralainy hospital</name>
      <address>
        <city>Giza</city>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Algazeerah</name>
      <address>
        <city>Giza</city>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>November 16, 2019</study_first_submitted>
  <study_first_submitted_qc>November 19, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 20, 2019</study_first_posted>
  <last_update_submitted>April 26, 2021</last_update_submitted>
  <last_update_submitted_qc>April 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Aljazeera Hospital</investigator_affiliation>
    <investigator_full_name>Mahmoud Alalfy</investigator_full_name>
    <investigator_title>Lecturer in national research crntre and Algezzera hospital ,egypt</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chromium</mesh_term>
    <mesh_term>Metformin</mesh_term>
    <mesh_term>Citric Acid</mesh_term>
    <mesh_term>Sodium Citrate</mesh_term>
    <mesh_term>Clomiphene</mesh_term>
    <mesh_term>Enclomiphene</mesh_term>
    <mesh_term>Zuclomiphene</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

